© CNP
Senate Committee on Health, Education, Labor, and Pensions hearing to examine infant formula crisis, focusing on addressing the shortage and getting formula on shelves
WASHINGTON (AP) — The head of the Food and Drug Administration faced a congressional grilling over a months-long delay in inspecting the plant at the center of a nationwide baby formula shortage.
FDA Commissioner Robert Califf faced questions Wednesday from House lawmakers probing the formula shortage. Califf called the response “too slow” and “not optimal.”
Lawmakers also heard from three formula executives, including Abbott Nutrition, which apologized for contamination issues at a factory that contributed to the shortage. The company says it’s on track to reopen its plant next month which will eventually help replenish supplies of popular and specialty formulas.
—Copyright 2022 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
